April 29, 2024, 2:48 p.m. | Ioanna Lykiardopoulou

The Next Web thenextweb.com


Paris-based Klineo has raised €2mn for its AI platform that facilitates access to cancer clinical trials. Klineo’s platform connects doctors and patients directly with relevant clinical trials. It provides trial search, contact with medical centres, as well as real-time updates and notifications when a new clinical trial matches the patient’s criteria. The startup’s solution currently covers trials on skin cancer, breast cancer, and lymphoma. Klineo was founded in 2021 by oncologist Dr Arnaud Bayle and two engineers, Thomas Peyresblanques and …

access ai platform cancer clinical clinical trial clinical trials deep tech doctors french medical notifications paris patients platform real-time real-time updates search startup startups and technology updates

Software Engineer for AI Training Data (School Specific)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Python)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Tier 2)

@ G2i Inc | Remote

Data Engineer

@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania

Artificial Intelligence – Bioinformatic Expert

@ University of Texas Medical Branch | Galveston, TX

Lead Developer (AI)

@ Cere Network | San Francisco, US